VYGR
Voyager Therapeutics Inc
2.70$
-4.3%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | -153.7% | – | – | – | – | – | – | – | – | – | |
| – | +41.3% | -10.4% | +16.4% | -18.7% | -10.7% | +0.3% | +5.0% | -12.5% | +12.6% | -45.9% | +60.1% | – | |
| – | +5.8% | +17.3% | +13.1% | -15.1% | +8.9% | -1.7% | +12.5% | -16.3% | +1.8% | -29.3% | -2.2% | – | |
| – | -3,040.5% | – | -139.8% | – | – | -170.8% | – | – | – | – | – | – | |
| – | -3.5% | +183.6% | -54.8% | -73.3% | -39.9% | +324.5% | +67.9% | -81.3% | +202.4% | -97.8% | +0.0% | – | |
| – | – | -458.0% | -62.6% | – | -142.3% | – | -95.3% | +1,704.9% | +35.9% | -82.9% | +90.0% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +39.0% | +24,433.9% | -99.5% | -97.5% | +4,000.0% | -85.7% | +525.6% | -83.4% | +60.0% | +2,350.0% | -12.8% | – | |
| – | – | +2,038.6% | -188.6% | – | -213.1% | – | -1,009.5% | – | +1,359.7% | -227.1% | – | – | |
| – | – | – | -157.5% | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.